DEVELOPMENT OF THE RECYCLING PROCEDURE FOR RAPID ANTIGEN TESTS
Abstract
The article presents the problem of rapid antigen tests when they become mass waste after use. Based on this, the hypothesis was made that rapid antigen tests can be recycled. Rapid antigen tests, which were used in the Covid-19 epidemic to quickly detect infections in the population or to confirm the presence of the Sars-Cov 2 virus in patients, were intended to limit the spread of the epidemic. To confirm the hypothesis of recycling for rapid antigen tests, the LFIA-REC ATP 150 project was prepared, which was selected for co-financing by the Norwegian Fund.
Rapid antigen tests consist of a sample and conjugate pad, detectable or nitrocellulose membranes and absorbent pads and a plastic case. The function of the sample pad is to evenly absorb the sample (mucus, blood) and lead it to the conjugate pad with a steady flow. Gold nanoparticles (labels) are deposited on the conjugate pad. The key is that the gold nanoparticles are conjugated with capture molecules capable of binding to potentially present antibodies or virus in the sample.
The scope of the research problem thus required the inclusion of various characterization techniques that must be applied to the individual material in the rapid antigen test to subsequently develop an efficient recycling process for the rapid antigen tests. The result of the research presented in this paper represents a newly developed algorithm of characterization techniques, which includes a recommended description of the preparation of samples of key materials from rapid antigen tests. This algorithm successfully achieved the characterization of gold nanoparticles from rapid antigen tests. Based on the developed algorithm, the final part of the project will validate the recycling process of rapid antigen tests, so that they can be recycled, i.e. gold nanoparticles or plastic used in new products. The paper presents the algorithm of characterization techniques with a description of the preparation of material samples from rapid antigen tests.
References
2. Strategija Razvoja Slovenije 2030 Available online: https://www.gov.si/assets/ministrstva/MKRR/Strategija-razvoja-Slovenije-2030/Strategija_razvoja_Slovenije_2030.pdf.
3. Agenda Za Trajnostni Razvoj Do Leta 2030 Available online: https://www.gov.si/assets/ministrstva/MZZ/Dokumenti/multilaterala/razvojno-sodelovanje/publikacije/Agenda_za_trajnostni_razvoj_2030.pdf.
4. The European Green Deal Available online: https://commission.europa.eu/strategy-and-policy/priorities-2019-2024/european-green-deal_en.
5. Paris Agreement Available online: https://treaties.un.org/pages/ViewDetails.aspx?src=TREATY&mtdsg_no=XXVII-7-d&chapter=27&clang=_en.
6. U.S. COVID Public Health Emergency Is Ending. Here’s What That Means Available online: https://www.scientificamerican.com/article/u-s-covid-public-health-emergency-is-ending-heres-what-that-means/.
7. Unused Covid Tests Worth Almost $160m Could Be Wasted, Health Minister Wants Solution Found Available online: https://www.nzherald.co.nz/nz/politics/unused-covid-tests-worth-almost-160m-could-be-wasted-health-minister-wants-solution-found/47PXEJ7HBFGANMIRD6XKTSBXZU/.
8. Merck Millipore Rapid Lateral Flow Test Strips Considerations for Product Development. Merck Millipore 2013.
9. Bayin, Q.; Huang, L.; Ren, C.; Fu, Y.; Ma, X.; Guo, J. Anti-SARS-CoV-2 IgG and IgM Detection with a GMR Based LFIA System. Talanta 2021, 227, 122207, doi:10.1016/j.talanta.2021.122207.
10. Pati, P.; McGinnis, S.; Vikesland, P.J. Waste Not Want Not: Life Cycle Implications of Gold Recovery and Recycling from Nanowaste. Environ. Sci. Nano 2016, 3, 1133–1143, doi:10.1039/c6en00181e.
11. Oestreicher, V.; García, C.S.; Soler-Illia, G.J.A.A.; Angelomé, P.C. Gold Recycling at Laboratory Scale: From Nanowaste to Nanospheres. ChemSusChem 2019, 12, 4882–4888, doi:10.1002/cssc.201901488.
12. Gu, X.; Xu, Z.; Gu, L.; Xu, H.; Han, F.; Chen, B.; Pan, X. Preparation and Antibacterial Properties of Gold Nanoparticles: A Review. Environ. Chem. Lett. 2021, 19, 167–187, doi:10.1007/s10311-020-01071-0.
13. Wang, W.; Wang, J.; Ding, Y. Gold Nanoparticle-Conjugated Nanomedicine: Design, Construction, and Structure–Efficacy Relationship Studies. J. Mater. Chem. B 2020, 8, 4813–4830, doi:10.1039/C9TB02924A.
14. Kang, M.S.; Lee, S.Y.; Kim, K.S.; Han, D.-W. State of the Art Biocompatible Gold Nanoparticles for Cancer Theragnosis. Pharmaceutics 2020, 12.
15. Sani, A.; Cao, C.; Cui, D. Toxicity of Gold Nanoparticles (AuNPs): A Review. Biochem. Biophys. Reports 2021, 26, 100991, doi:https://doi.org/10.1016/j.bbrep.2021.100991.
16. Švarc, T.; Majerič, P.; Feizpour, D.; Jelen, Ž.; Zadravec, M.; Gomboc, T.; Rudolf, R. Recovery Study of Gold Nanoparticle Markers from Lateral Flow Immunoassays. Materials (Basel). 2023, 16.